GLECKEL LOUIS MD 4
4 · ProPhase Labs, Inc. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
GLECKEL LOUIS MD
10% Owner
Transactions
- Award
Option (right to buy)
2024-03-17+70,000→ 70,000 totalExercise: $6.00Exp: 2031-03-17→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date.